Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1861 to 1875 of 9020 results

  1. Sparsentan for treating focal segmental glomerulosclerosis in people 8 years and over [ID3955]

    Awaiting development Reference number: GID-TA10867 Expected publication date: TBC

  2. Ibalizumab for treating adults infected with multidrug resistant HIV-1 for whom it is not possible to construct a suppressive anti-viral regimen [ID2720]

    Awaiting development Reference number: GID-TA10657 Expected publication date: TBC

  3. Perampanel for adjunctive treatment of partial onset or generalised tonic-clonic seizures in children aged below 12 years with epilepsy [ID1587]

    Awaiting development Reference number: GID-TA10519 Expected publication date: TBC

  4. Ensitrelvir for treating COVID-19 [ID6231]

    Awaiting development Reference number: GID-TA11224 Expected publication date: TBC

  5. Doravirine–islatravir for treating HIV-1 in people with virological suppression on antiretroviral therapy [TSID12173]

    Topic prioritisation

  6. BPMpathway for rehabilitation support in joint replacement surgery, (MIB319)

    Topic prioritisation

  7. Urolon, (MT821)

    Topic prioritisation

  8. Jada, (MT826)

    Topic prioritisation

  9. The Insides System chyme reinfusion system (MT682)

    Topic prioritisation

  10. MT684 Smart Peak Flow for monitoring asthma

    Topic prioritisation

  11. MT650 24/7 EEG SubQ for people with epilepsy

    Topic prioritisation

  12. MMprofiler for prognostic risk classification in multiple myeloma (MT623) (MIB270)

    Topic prioritisation

  13. HealthVCF for detecting vertebral compression fractures on CT scans MT581 (MIB267)

    Topic prioritisation

  14. RenalSense Clarity RMS for acute kidney injury MT601 (MIB256)

    Topic prioritisation

  15. Moor LDLS-BI for assessing burn depth and healing potential in children and adults

    Topic prioritisation